Keywords: coronavirus, severe acute respiratory syndrome, vaccines, inactivated, beta-Propiolactone, adjuvant
Konrad Stadler, Anjeanette Roberts, Stephan Becker, Leatrice Vogel, Markus Eickmann, Larissa Kolesnikova, Hans-Dieter Klenk, Brian Murphy, Rino Rappuoli, Sergio Abrignani, Kanta Subbarao
Centers for Disease Control and Prevention
Infectious and parasitic diseases, Medicine